Cash Flow Kiniksa Pharmaceuticals International Plc Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-36.00
-16.00
11.00
-156.00
-156.00
-163.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
24.00
1.00
-22.00
0.00
-4.00
-17.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
25.00
13.00
5.00
-126.00
-136.00
-158.00
Cash Flow from Investing Activities
37.00
-29.00
-8.00
128.00
-23.00
49.00
Cash Flow from Financing Activities
12.00
1.00
2.00
5.00
227.00
84.00
Net Cash Inflow / Outflow
75.00
-14.00
0.00
8.00
67.00
-25.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kiniksa Pharmaceuticals International Plc
Figures in Million
No Consolidated Results Declared by Selected Peer
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 93.14% vs 129.05% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
25.69
13.30
93.14%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
